345 related articles for article (PubMed ID: 19147618)
1. TWEAK and its receptor Fn14 in the synovium of patients with rheumatoid arthritis compared to psoriatic arthritis and its response to tumour necrosis factor blockade.
van Kuijk AW; Wijbrandts CA; Vinkenoog M; Zheng TS; Reedquist KA; Tak PP
Ann Rheum Dis; 2010 Jan; 69(1):301-4. PubMed ID: 19147618
[TBL] [Abstract][Full Text] [Related]
2. Safety, tolerability, pharmacokinetics, and pharmacodynamics of anti-TWEAK monoclonal antibody in patients with rheumatoid arthritis.
Wisniacki N; Amaravadi L; Galluppi GR; Zheng TS; Zhang R; Kong J; Burkly LC
Clin Ther; 2013 Aug; 35(8):1137-49. PubMed ID: 23928094
[TBL] [Abstract][Full Text] [Related]
3. Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA.
Kamijo S; Nakajima A; Kamata K; Kurosawa H; Yagita H; Okumura K
Rheumatology (Oxford); 2008 Apr; 47(4):442-50. PubMed ID: 18310134
[TBL] [Abstract][Full Text] [Related]
4. TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis.
Dharmapatni AA; Smith MD; Crotti TN; Holding CA; Vincent C; Weedon HM; Zannettino AC; Zheng TS; Findlay DM; Atkins GJ; Haynes DR
Arthritis Res Ther; 2011 Mar; 13(2):R51. PubMed ID: 21435232
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of TNF-induced IL-6 by the TWEAK-Fn14 interaction in rheumatoid arthritis fibroblast like synoviocytes.
Yamana J; Morand EF; Manabu T; Sunahori K; Takasugi K; Makino H; Yamamura M
Cell Immunol; 2012; 272(2):293-8. PubMed ID: 22055894
[TBL] [Abstract][Full Text] [Related]
6. Synovial features of patients with rheumatoid arthritis and psoriatic arthritis in clinical and ultrasound remission differ under anti-TNF therapy: a clue to interpret different chances of relapse after clinical remission?
Alivernini S; Tolusso B; Petricca L; Bui L; Di Sante G; Peluso G; Benvenuto R; Fedele AL; Federico F; Ferraccioli G; Gremese E
Ann Rheum Dis; 2017 Jul; 76(7):1228-1236. PubMed ID: 28119289
[TBL] [Abstract][Full Text] [Related]
7. TWEAK promotes the production of Interleukin-17 in rheumatoid arthritis.
Park JS; Park MK; Lee SY; Oh HJ; Lim MA; Cho WT; Kim EK; Ju JH; Park YW; Park SH; Cho ML; Kim HY
Cytokine; 2012 Oct; 60(1):143-9. PubMed ID: 22819243
[TBL] [Abstract][Full Text] [Related]
8. [The expression of TWEAKR/Fn14 in Rheumatoid arthritis fibroblast-like synoviocytes].
Xia LP; Fang F; Lu J; Xiao WG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jun; 26(6):575-7. PubMed ID: 20487651
[TBL] [Abstract][Full Text] [Related]
9. The TWEAK-Fn14 system as a potential drug target.
Wajant H
Br J Pharmacol; 2013 Oct; 170(4):748-64. PubMed ID: 23957828
[TBL] [Abstract][Full Text] [Related]
10. GM-CSF Expression and Macrophage Polarization in Joints of Undifferentiated Arthritis Patients Evolving to Rheumatoid Arthritis or Psoriatic Arthritis.
Fuentelsaz-Romero S; Cuervo A; Estrada-Capetillo L; Celis R; García-Campos R; Ramírez J; Sastre S; Samaniego R; Puig-Kröger A; Cañete JD
Front Immunol; 2020; 11():613975. PubMed ID: 33679701
[TBL] [Abstract][Full Text] [Related]
11. Detailed analysis of the cell infiltrate and the expression of mediators of synovial inflammation and joint destruction in the synovium of patients with psoriatic arthritis: implications for treatment.
van Kuijk AW; Reinders-Blankert P; Smeets TJ; Dijkmans BA; Tak PP
Ann Rheum Dis; 2006 Dec; 65(12):1551-7. PubMed ID: 16728461
[TBL] [Abstract][Full Text] [Related]
12. Expression of IL-20 in synovium and lesional skin of patients with psoriatic arthritis: differential response to alefacept treatment.
Lebre MC; Jonckheere CL; Kraan MC; van Kuijk AW; Bos JD; de Rie M; Gerlag DM; Tak PP
Arthritis Res Ther; 2012 Sep; 14(5):R200. PubMed ID: 23006144
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?
van Baarsen LG; Lebre MC; van der Coelen D; Aarrass S; Tang MW; Ramwadhdoebe TH; Gerlag DM; Tak PP
Arthritis Res Ther; 2014 Aug; 16(4):426. PubMed ID: 25146432
[TBL] [Abstract][Full Text] [Related]
14. The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system.
Echeverry R; Wu F; Haile WB; Wu J; Yepes M
J Neuroinflammation; 2012 Mar; 9():45. PubMed ID: 22394384
[TBL] [Abstract][Full Text] [Related]
15. Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention.
Gu L; Dai L; Cao C; Zhu J; Ding C; Xu HB; Qiu L; Di W
PLoS One; 2013; 8(3):e57436. PubMed ID: 23469193
[TBL] [Abstract][Full Text] [Related]
16. Blocking TWEAK-Fn14 interaction inhibits hematopoietic stem cell transplantation-induced intestinal cell death and reduces GVHD.
Chopra M; Brandl A; Siegmund D; Mottok A; Schäfer V; Biehl M; Kraus S; Bäuerlein CA; Ritz M; Mattenheimer K; Schwinn S; Seher A; Grabinger T; Einsele H; Rosenwald A; Brunner T; Beilhack A; Wajant H
Blood; 2015 Jul; 126(4):437-44. PubMed ID: 26012567
[TBL] [Abstract][Full Text] [Related]
17. Effects of polymorphisms in TRAILR1 and TNFR1A on the response to anti-TNF therapies in patients with rheumatoid and psoriatic arthritis.
Morales-Lara MJ; Cañete JD; Torres-Moreno D; Hernández MV; Pedrero F; Celis R; García-Simón MS; Conesa-Zamora P
Joint Bone Spine; 2012 Dec; 79(6):591-6. PubMed ID: 22480748
[TBL] [Abstract][Full Text] [Related]
18. TWEAK/Fn14 activation induces keratinocyte proliferation under psoriatic inflammation.
Cheng H; Xu M; Liu X; Zou X; Zhan N; Xia Y
Exp Dermatol; 2016 Jan; 25(1):32-7. PubMed ID: 26264384
[TBL] [Abstract][Full Text] [Related]
19. Synovial synoviolin in relation to response to TNF blockade in patients with rheumatoid arthritis and psoriatic arthritis.
Klaasen R; Wijbrandts CA; van Kuijk AW; Pots D; Gerlag DM; Tak PP
Ann Rheum Dis; 2012 Jul; 71(7):1260-1. PubMed ID: 22345123
[No Abstract] [Full Text] [Related]
20. Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity.
Salzmann S; Seher A; Trebing J; Weisenberger D; Rosenthal A; Siegmund D; Wajant H
J Biol Chem; 2013 May; 288(19):13455-66. PubMed ID: 23532848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
